Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.
about
Optimal management of seizures associated with tuberous sclerosis complex: current and emerging optionsOptimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic reviewProfile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapyTuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus ConferenceOphthalmic manifestations of tuberous sclerosis: a review.Unilateral giant renal angiomyolipoma and pulmonary lymphangioleiomyomatosisEfficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study.Neuroimaging Findings in Pediatric Genetic Skeletal Disorders: A Review.Diffuse Cystic Lung Disease. Part I.The genomic landscape of tuberous sclerosis complexNatural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex.Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group.Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND ChecklistRETRACTED: Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis.Tuberous Sclerosis: A New Frontier in Targeted Treatment of AutismAssociation between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy.Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis.Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study.EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complexTuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patientsDifferentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role.Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers.Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.A Case of Tuberous Sclerosis Without Multiorgan InvolvementEverolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutationComparison of Color Fundus Photography, Infrared Fundus Photography, and Optical Coherence Tomography in Detecting Retinal Hamartoma in Patients with Tuberous Sclerosis Complex.Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®)Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial.Everolimus for subependymal giant cell astrocytoma: 5-year final analysis.mTOR, a Potential Target to Treat Autism Spectrum Disorder.Coexistence of Autism Spectrum Disorders Among Three Children with Tuberous Sclerosis Complex: Case reports and review of literature.Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide.Structured assessment and followup for patients with hereditary kidney tumour syndromes.mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders.The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.Annual review of children with tuberous sclerosis.Tuberous sclerosis complex: the past and the future.
P2860
Q22305852-03F09FE5-F0E1-40BF-916A-70F79C1A9F73Q28071646-7A3A9F38-84E8-45D1-8655-08D6879FC9B1Q28078328-7E9B42B1-D2F0-4050-B527-FA8B88A4B5C4Q28298922-C3DEC192-4EB7-4129-A4D5-29E7061302F8Q30248841-E5F05031-693E-40B4-98D6-5A14DAFF12B0Q30354842-060FDE4B-6007-425E-9890-ADD0E7E35F76Q31140724-4C8F2F69-8C4D-4E5F-9319-9219245D0B86Q31150423-A7713A22-BE5A-485F-8E81-F5F57C9BF4D2Q33722950-DB804600-D665-4C19-97F0-56511C49C8F2Q33826893-165500C3-F1E0-400E-8D71-D5E7DB7AAFF3Q34374868-D1DF7E39-DA6B-437E-B1E4-88DF9F10FF71Q34636117-9FE214F8-A513-4250-8CF5-ED3570D8EA9EQ35115152-C3D842BA-174C-4E15-BF74-40D92096F948Q35593184-A3628F11-71F1-4DE6-BE45-559EC9B95039Q35758949-18A86826-A8DB-4FA0-BB33-6F5589D2FF98Q35811772-2EF8A55A-3B9B-4363-8E1F-FD85F56E0DB2Q35836319-C7506B1D-471A-4F71-B2E0-C5FE3433B4C8Q35976089-645FB8A6-1059-41B5-AF41-3B726ABA1EE9Q36015287-CDD707DA-738D-4E40-B4DB-7CA81CA20370Q36063084-F633B71C-555F-4EB6-AD72-304356737325Q36098018-DE2537BA-C859-4EBF-81DF-2669D5B0CC21Q36241426-B2B3296E-6D59-47BA-AE2E-BF98F60CF4FCQ36250754-608FE2E4-9992-44D9-BD16-7828A9C5C8A4Q36326114-B94E6A8D-936B-4FF4-AEF5-F85DB35B231FQ36344050-3D42E619-D386-46F2-9A26-B762E63186C2Q36405543-9E23460A-438B-4C84-9556-CD394560F0CAQ36718024-ED58085B-B265-4844-9546-E66CF2D58404Q36929881-77AC8523-65E9-4C19-B2F6-35B555DC25E4Q36930159-2381A1E8-3FC4-45F3-B715-8FDF392739A9Q37143763-D037C32C-638C-496C-920F-67564AF930BCQ37286103-F524DFE0-BF5A-43BD-BDAB-363D18DC6158Q37337337-19B1DE5A-5F1C-47D6-82EC-99C4E4C851E5Q37350523-B4BE7805-29F6-458E-8F8A-946A0D8BB7C7Q37469966-0EC4AD04-C84D-44B4-8F78-2FC05755A7F1Q37644172-2F7FA760-D929-4E4E-970C-0FBE59D42F0EQ37666156-F56F0D2E-571A-4094-B72D-0D5ADEEB8C7EQ37697798-F24C0FF0-A377-433C-87DA-216D59D0483BQ38199329-22981BAC-1497-4DEA-B92D-120B8E5BCDD3Q38238907-BF9639AC-8183-4335-AAAA-5255FF6443CEQ38297624-EB6BF779-1A0F-47BD-A536-E75370700544
P2860
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tuberous sclerosis complex sur ...... Complex Consensus Conference.
@ast
Tuberous sclerosis complex sur ...... Complex Consensus Conference.
@en
type
label
Tuberous sclerosis complex sur ...... Complex Consensus Conference.
@ast
Tuberous sclerosis complex sur ...... Complex Consensus Conference.
@en
prefLabel
Tuberous sclerosis complex sur ...... Complex Consensus Conference.
@ast
Tuberous sclerosis complex sur ...... Complex Consensus Conference.
@en
P2093
P2860
P1433
P1476
Tuberous sclerosis complex sur ...... Complex Consensus Conference.
@en
P2093
Darcy A Krueger
Hope Northrup
International Tuberous Sclerosis Complex Consensus Group
P2860
P304
P356
10.1016/J.PEDIATRNEUROL.2013.08.002
P577
2013-10-01T00:00:00Z